medrol 16mg tabletas.
pfizer, s.a. - metilprednisolona - metilprednisolona....16 mg.
medrol 4 mg
pfizer pfe pharmaceuticals israel ltd - methylprednisolone - tablets - methylprednisolone 4 mg - methylprednisolone - methylprednisolone - anti-allergic, anti-inflammatory for treatment of allergic conditions such as asthma and diverse skin disease, inflammatory states and arthritis.
medrol- methylprednisolone tablet
zoetis inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - the indications for medrol tablets are the same as those for other anti-inflammatory steroids and comprise the various collagen, dermal, allergic, ocular, otic, and musculoskeletal conditions known to be responsive to the anti-inflammatory corticosteroids. representative of the conditions in which the use of steroid therapy and the benefits to be derived therefrom have had repeated confirmation in the veterinary literature are: (1) dermal conditions, such as non-specific eczema, summer dermatitis, and burns; (2) allergic manifestations, such as acute urticaria, allergic dermatitis, drug and serum reactions, bronchial asthma, and pollen sensitivities; (3) ocular conditions, such as iritis, iridocyclitis, secondary glaucoma, uveitis, and chorioretinitis; (4) otic conditions, such as otitis externa; (5) musculoskeletal conditions, such as myositis, rheumatoid arthritis, osteoarthritis, and bursitis; (6) various chronic or recurrent diseases of unknown etiology such as ulcerative colitis and nephrosis. in acute a
medrol
pfizer new zealand limited - methylprednisolone 100mg - tablet - 100 mg - active: methylprednisolone 100mg - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer
medrol
pfizer new zealand limited - methylprednisolone 4mg; methylprednisolone 4mg - tablet - 4 mg - active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate liquid paraffin purified water sucrose active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate maize starch purified water sucrose - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer
medrol 4mg 4mg/tablet
modern pharmaceutical company italy - 30's hdpe bottle - tablet - 4mg/tablet - endocrine system-corticosteroids
medrol tablet
pfizer laboratories limited 197 lenana road - nairobi - methylprednisolone - tablet - 4mg - plain weak corticosteroids (group i) for topical
medrol tablets 2mg (メドロール錠2mg)
pfizer pharmaceuticals inc. - methylprednisolone - pink tablet with split line, major axis: 8.2 mm, minor axis: 5.6 mm, thickness: 2.3 mm
medrol tablets 4mg (メドロール錠4mg)
pfizer pharmaceuticals inc. - methylprednisolone - white tablet with split line, major axis: 8.2 mm, minor axis: 5.6 mm, thickness: 2.2 mm
medrol methylprednisolone tablet
remedyrepack inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg